Articles by University of Texas MD Anderson Cancer Center

Study validates the safety of combined delivery of engineered virus with immunotherapy to improve survival rate and quality of life in patients

Concurrent intrathecal and intravenous treatment is safe and improves outcomes in a subset of patients with melanoma

This is the first randomized study to report on the role of combination checkpoint inhibitors for early stage NSCLC

Based on gene expression, researchers identified potential therapeutic targets for each subtype

Called CopyKAT, the computational tool enables researchers to gain new insights when analyzing solid tumor samples

If validated, the new tool may help direct patients with gastric cancer toward more effective treatments

The study suggests that increasing the protein's activity in T cells may enhance the effectiveness of immunotherapy

Study points to strategies for improving outcomes with immunotherapy in rare cancer type